Summary
The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 µg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.
The global Iron Chelation Drug market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Apotex Inc. (Canada)
Cipla (India)
Novartis (Switzerland)
Sun Pharma (India)
Natco Pharma (India)
Major applications as follows:
Transfusional Iron Overload
NTDT Caused Iron Overload
Major Type as follows:
Deferoxamine
Deferiprone
Deferasirox
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Interested in this report?
Get your sample now!
Table of Contents
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Apotex Inc. (Canada)
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Cipla (India)
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 Novartis (Switzerland)
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Sun Pharma (India)
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Natco Pharma (India)
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Transfusional Iron Overload
4.1.1 Overview
4.1.2 Transfusional Iron Overload Market Size and Forecast
4.2 NTDT Caused Iron Overload
4.2.1 Overview
4.2.2 NTDT Caused Iron Overload Market Size and Forecast
5 Market by Type
5.By Deferoxamine
5.1 Deferoxamine
5.1.1 Overview
5.1.2 Deferoxamine Market Size and Forecast
5.2 Deferiprone
5.2.1 Overview
5.2.2 Deferiprone Market Size and Forecast
5.3 Deferasirox
5.3.1 Overview
5.3.2 Deferasirox Market Size and Forecast
6 Price Overview
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 Conclusion
Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Apotex Inc. (Canada)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Cipla (India)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Novartis (Switzerland)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Sun Pharma (India)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Natco Pharma (India)
Fig Global Iron Chelation Drug Market Size and CAGR 2013-2018 (Million USD)
Fig Global Iron Chelation Drug Market Size and CAGR 2013-2018 (Volume)
Fig Global Iron Chelation Drug Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Iron Chelation Drug Market Forecast and CAGR 2019-2025 (Volume)
Fig Transfusional Iron Overload Market Size and CAGR 2013-2018 (Million USD)
Fig Transfusional Iron Overload Market Size and CAGR 2013-2018 (Volume)
Fig Transfusional Iron Overload Market Forecast and CAGR 2019-2025 (Million USD)
Fig Transfusional Iron Overload Market Forecast and CAGR 2019-2025 (Volume)
Fig NTDT Caused Iron Overload Market Size and CAGR 2013-2018 (Million USD)
Fig NTDT Caused Iron Overload Market Size and CAGR 2013-2018 (Volume)
Fig NTDT Caused Iron Overload Market Forecast and CAGR 2019-2025 (Million USD)
Fig NTDT Caused Iron Overload Market Forecast and CAGR 2019-2025 (Volume)
Fig Deferoxamine Market Size and CAGR 2013-2018 (Million USD)
Fig Deferoxamine Market Size and CAGR 2013-2018 (Volume)
Fig Deferoxamine Market Forecast and CAGR 2019-2025 (Million USD)
Fig Deferoxamine Market Forecast and CAGR 2019-2025 (Volume)
Fig Deferiprone Market Size and CAGR 2013-2018 (Million USD)
Fig Deferiprone Market Size and CAGR 2013-2018 (Volume)
Fig Deferiprone Market Forecast and CAGR 2019-2025 (Million USD)
Fig Deferiprone Market Forecast and CAGR 2019-2025 (Volume)
Fig Deferasirox Market Size and CAGR 2013-2018 (Million USD)
Fig Deferasirox Market Size and CAGR 2013-2018 (Volume)
Fig Deferasirox Market Forecast and CAGR 2019-2025 (Million USD)
Fig Deferasirox Market Forecast and CAGR 2019-2025 (Volume)
